 |
|
|
| |
Common Adverse Events in Clinical Studies of People Using Lenacapavir for HIV Treatment
|
| |
| |
Glasgow 2022 Oct 23-26
Andrea Antinori,1 Francesco Castelli,2 Sylvie Ronot-Bregigeon,3 Yazdan Yazdanpanah,4 Rachel Safran,5 Daniel S. Berger,6 Paul Cook,7
Gary Ian Sinclair,8 Hui Wang,9 Gary Saunders,9 Terry Farrow,9 Hadas Dvory-Sobol,9 Martin S. Rhee,9 Jared Baeten,9 Samir Gupta10
1IRCCS Istituto Nazionale per le Malattie Infettive "Lazzaro Spallanzani," Roma, Italy; 2Università degli Studi di Brescia, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Italy; 3Hôpital Sainte Marguerite, Aix Marseille Université, Marseille, France; 4Hôpital Bichat-Claude-Bernard, Paris, France; 5MultiCare Rockwood Internal Medicine & HIV Clinic, Spokane, Washington, US; 6University of Illinois, Northstar Healthcare Medical Center, Chicago, Illinois, US; 7East Carolina University, Greenville, North Carolina, US; 8Prism Health North Texas, Oak Cliff Health Center, Dallas, Texas, US; 9Gilead Sciences, Inc., Foster City, California, US; 10Indiana University School of Medicine, Indianapolis, Indiana, US
|
| |
|
|
|
|
|
